Der var ingen signifikant forskel i HIV- 1 transmission fødselstallene efter 6 - 8 uger mellem VIRAMUNE gruppen (5, 7%, n = 652) og zidovudin - plus lamivudingruppen (3, 6%, n = 649).
There was no significant difference in HIV-1 transmission rates through 6 to 8 weeks between the VIRAMUNE group (5.7%, n = 652) and the zidovudine plus lamivudine group (3.6%, n = 649).